Cytek Biosciences, Inc.
CTKB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $93 | $75 | $95 | $99 |
| Short-Term Investments | $168 | $187 | $170 | $179 |
| Receivables | $62 | $57 | $55 | $61 |
| Inventory | $52 | $49 | $45 | $44 |
| Other Curr. Assets | $13 | $15 | $14 | $14 |
| Total Curr. Assets | $388 | $383 | $381 | $396 |
| Property Plant & Equip (Net) | $29 | $35 | $28 | $28 |
| Goodwill | $17 | $17 | $17 | $17 |
| Intangibles | $18 | $19 | $19 | $20 |
| Long-Term Investments | $2 | $0 | $0 | $0 |
| Tax Assets | $38 | $36 | $34 | $33 |
| Other NC Assets | $3 | $5 | $5 | $5 |
| Total NC Assets | $106 | $110 | $102 | $103 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $495 | $493 | $483 | $500 |
| Liabilities | – | – | – | – |
| Payables | $8 | $7 | $6 | $6 |
| Short-Term Debt | $13 | $9 | $8 | $8 |
| Tax Payable | $0 | $4 | $4 | $4 |
| Deferred Revenue | $29 | $30 | $29 | $27 |
| Other Curr. Liab. | $26 | $24 | $21 | $24 |
| Total Curr. Liab. | $75 | $73 | $68 | $68 |
| LT Debt | $22 | $15 | $8 | $9 |
| Deferred Rev, NC | $16 | $17 | $16 | $16 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $11 | $11 | $11 |
| Total NC Liab. | $41 | $42 | $35 | $36 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13 | $17 | $11 | $11 |
| Total Liabilities | $116 | $116 | $103 | $104 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$58 | -$52 | -$47 | -$35 |
| AOCI | $1 | -$0 | -$1 | $0 |
| Other Equity | $435 | $430 | $427 | $431 |
| Total Equity | $379 | $378 | $380 | $396 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $495 | $493 | $483 | $500 |
| Net Debt | -$58 | -$52 | -$79 | -$82 |